Q08499 (PDE4D_HUMAN) Homo sapiens (Human)

3',5'-cyclic-AMP phosphodiesterase 4D UniProtKBInterProSTRINGInteractive Modelling

809 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6; Isoform 7; Isoform 8; Isoform 9; Isoform 10; Isoform 11; Isoform 12); 1 identical sequence: Homo sapiens: A0A140VJR0

Available Structures

112 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
crystal structure of PDE4D catalytic domain and zardaverine complexhomo-6-mer388-715
99.69ZN;MG;ZAR;
PDE4 complexed with inhibitorhomo-4-mer387-738
100.03KQ;ZN;MG;
Crystal structure of PDE4D2 in complex with inhibitor LEO39652homo-4-mer381-714
100QDT; 28×EDO;DMS;MG;ZN;
Crystal structure of PDE4D in complex with L-869298homo-4-mer381-714
100ZN;MG;M98;
Crystal structure of PDE4D2 in complex with (R,S)-rolipramhomo-4-mer381-714
100ZN;ROL;
Crystal structure of PDE4D2 in complex with inhibitor L-869299homo-4-mer381-714
100ZN;MG;M99;
Structure of PDE4D2-IBMXhomo-4-mer381-714
100ZN;MG;IBM;
The Crystal Structure of AMP-Bound PDE4 Suggests a Mechanism for Phosphodiesterase Catalysishomo-4-mer381-714
100ZN;AMP;
Three dimensional structures of PDE4D in complex with roliprams and implication on inhibitor select…homo-4-mer381-714
100ZN;ROL;
Crystal structure of the PDE4D catalytic domain in complex with GEBR-42ahomo-2-mer382-714
100ZN;MG; 28×EDO;T3K;
Crystal structure of the PDE4D catalytic domain in complex with GEBR-41bhomo-2-mer382-714
100S8Q;ZN;MG; 14×EDO;
Crystal structure of the PDE4D catalytic domain in complex with GEBR-18ahomo-2-mer383-714
100ZN;MG;D0E;
Crystal structure of the PDE4D catalytic domain in complex with GEBR-32ahomo-2-mer385-714
100ZN;MG;EDO;DD5;D5N;
Crystal structure of the PDE4D catalytic domain in complex with GEBR-4ahomo-2-mer386-714
100ZN;MG;CZT;
Crystal structure of the PDE4D catalytic domain in complex with GEBR-7bhomo-2-mer386-714
100MG;ZN;CV8;GOL;
Crystal structure of the PDE4D catalytic domain in complex with GEBR-18bhomo-2-mer387-714
100ZN;MG;D0B;
Crystal structure of PDE4D catalytic domain in complex with arctigeninhomo-2-mer388-714
100ZN;MG;EQC; 26×EDO;
Structure of the PDE4D-cAMP complexhomo-2-mer388-714
99.69ZN;CMP;
Crystal structure of PDE4D2 in complex with inhibitor NPVhomo-2-mer388-714
100NPV;ZN;MG;
Crystal structure of PDE4D catalytic domain in complex with Apremilasthomo-2-mer388-714
100MG;ZN; 11×EDO;A9L;
The structure of the catalytic domain of human PDE4d with 4-(3-Butoxy-4-methoxyphenyl)methyl-2-imid…homo-2-mer388-714
100ZN;0MO;MG;
Crystal structure of PDE4D catalytic domain complexed with compound 21dhomo-2-mer388-714
100ZN;MG;AQL;
Crystal structure of PDE4D catalytic domain in complex with compound 36homo-2-mer388-713
100ZN;MG;FTX; 12×EDO;
Crystal structure of PDE4D complexed with benzbromaronehomo-2-mer388-713
100ZN;MG;R75;EDO;
Crystal structure of PDE4D complexed with ethaverine hydrochloridehomo-2-mer388-713
100VIC;MG;ZN;EDO;
The crystal structure of PDE4D with Amentoflavonehomo-2-mer388-713
100ZN;MG;A1D6Q;
Crystal structure of PDE4D complexed with a novel inhibitorhomo-2-mer389-713
100MG;ZN;AH6; 11×EDO;
Crystal structure of PDE4D complexed with a novel inhibitorhomo-2-mer389-713
100ZN;MG;AH9; 11×EDO;
Crystal structure of PDE4D complexed with a novel inhibitorhomo-2-mer389-713
100ZN;MG;AJX; 14×EDO;
Crystal structure of PDE4D complexed with a novel inhibitorhomo-2-mer389-713
100ZN;MG;AH3; 13×EDO;
Crystal structure of PDE4D complexed with a novel inhibitorhomo-2-mer389-713
100AKO;MG;ZN;EDO;
PDE4D complexed with inhibitorhomo-2-mer389-713
100.03GJ;ZN;
Crystal structure of PDE4D complexed with a novel inhibitorhomo-2-mer390-713
100ZN;MG; 10×EDO;AK0;
Crystal structure of PDE4D complexed with a novel inhibitorhomo-2-mer390-713
100ZN;MG;AH9; 15×EDO;
Crystal structure of PDE4D complexed with CX-4945homo-2-mer390-713
100MG;ZN;3NG;EDO;
Crystal structure of PDE4D complexed with a novel inhibitorhomo-2-mer390-713
100ZN;MG;AJL; 12×EDO;
Crystal structure of PDE4D complexed with 7b-1homo-2-mer390-713
100MG;ZN;W8E;EDO;
Crystal structure of PDE4D complexed with DCNhomo-2-mer390-713
100MG;ZN;W8O;EDO;
Crystal structure of PDE4D complexed with a novel inhibitorhomo-2-mer390-713
100ZN;MG;AKU;EDO;
Crystal structure of the PDE4D catalytic domain in complex with GEBR-26ghomo-2-mer392-715
100ZN;MG;D08;EDO;DMS;
PDE4D crystal structure in complex with small molecule inhibitorhomo-2-mer390-713
100.0ZN;MG;6Q2; 32×EDO;
Crystal structure of PDE4D complexed with a novel inhibitorhomo-2-mer390-713
100ZN;MG;AKU;EDO;
Crystal structure of human phosphodiesterase 4d (PDE4d) with papaverine.homo-2-mer388-711
100ZN;MG;EV1;
Crystal structure of PDE4D complexed with CVT-313homo-2-mer390-712
100AJR;MG;ZN;EDO;
Crystal structure of PDE4D complexed with glycyrrhisoflavonehomo-2-mer390-712
100ZN;MG;JN0;EDO;
Crystal structure of PDE4D complexed with licoisoflavone Ahomo-2-mer390-712
100ZN;MG;JU3;EDO;
Crystal structure of the PDE4D catalytic domain in complex with GEBR-54homo-2-mer392-714
100CZK;MG;ZN;EDO;
Crystal structure of PDE4D catalytic domain complexed with compound 22dhomo-2-mer390-712
100ZN;MG;AWI;
Crystal structure of the PDE4D catalytic domain in complex with GEBR-20bhomo-2-mer392-714
100ZN;MG;CZQ;
Crystal structure of PDE4D catalytic domain complexed with compound 23ahomo-2-mer390-712
100ZN;MG;B6V;
Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with T-48monomer326-718
100.0ZN;MG;KRD;
Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with BPN14770monomer326-718
100.0ZN;MG;KR7;BTB;SO4;EDO;
Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with T-49monomer326-718
100.0ZN;MG;KR4;
Crystal structure of human phosphodiesterase 4D with bound allosteric modulatormonomer326-714
100.015X;ZN;MG;EPE;
Crystal structure of human phosphodiesterase 4d with regulatory domain and d155871monomer327-714
100.0ZN;MG;CA;D71;
Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with BPN5004monomer390-734
100.0ZN;MG;E31;CL;
Crystal structure of human phosphodiesterase 4d with d155988/pmnpqmonomer380-714
100ZN;MG;SO4;988;EDO;
Crystal structure of PDE4D catalytic domain complexed with Selaginpulvilins Kmonomer381-714
100J20;ZN;MG;
Crystal structure of human phosphodiesterase 4d with d155871monomer384-714
100ZN;MG;SO4;D71;EOH;
Crystal structure of the catalytic domain of PDE4D2 with (S)-N-(3-{1-[1-(3-Cyclopropylmethoxy-4-dif…monomer384-714
100IHM;ZN;
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-048monomer383-713
100ZN;MG; 13×EDO;EPE;E6Z;
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-617monomer384-713
100ZN;MG;QWT; 15×EDO;PEG;DMS;EPE;
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-769monomer384-713
100ZN;MG; 19×EDO;J2E;EPE;
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-226monomer384-713
100ZN;MG; 21×EDO;PEG;D5T;
Crystal structure of human phosphodiesterase 4d with roliprammonomer384-713
100ZN;MG;SO4;ROL;EDO;
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-356monomer384-713
100ZN;MG; 15×EDO;PEG;D62;EPE;
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-656monomer384-713
100ZN;MG; 10×EDO;QWZ;
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-001monomer384-713
100ZN;MG;EDO;DTT;6M5;
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-768monomer384-713
100ZN;MG;EDO;EPE;RLW;
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-007monomer385-713
100ZN;MG; 20×EDO;PEG;EPE;E8H;
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-1439monomer385-713
100ZN;MG; 19×EDO;PEG;D68;EPE;NI;
Crystal structure of the catalytic domain of PDE4D2 with compound 10Dmonomer385-713
100ZN; 16×EDO;DMS;PEG;PO4;JN4;
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-637monomer385-713
100ZN;MG; 10×EDO;E3Q;
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-053monomer385-713
100ZN;MG; 12×EDO;PEG;DTT;
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-425monomer385-713
100ZN;MG;EDO;E6E;EPE;
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-1361monomer385-713
100ZN;MG; 13×EDO;DMS;863;EPE;
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH A TETRAFLUORANLINE COMPOUNDmonomer386-714
100.0ZN;MG;SO4;EOH;7DJ;
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-635monomer385-713
100ZN;MG;EDO;EPE;
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-654monomer385-713
100ZN;MG;EDO;EPE;
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-417monomer385-713
100ZN;MG;EDO;EPE;4I7;
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-3098monomer385-713
100ZN;MG;EDO;E6N;EPE;
Crystal structure of human phosphodiesterase 4d with roflumilastmonomer385-713
100.0ZN;MG;SO4;ROF;EDO;
Crystal structure of the catalytic domain of PDE4D2 with compound 2monomer385-712
1002SR;EDO;PEG;ZN;DMS;
Crystal structure of the catalytic domain of PDE4D2 complexed with compound 10dmonomer385-712
100ZN;J25;EDO;DMS;
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-1335monomer385-711
10015×EDO;PEG;ZN;FFZ;MG;EPE;
Crystal structure of the apo form of the catalytic domain of PDE4D2monomer385-711
10017×EDO;PEG;ZN;PO4;
Crystal structure of PDE4D catalytic domain complexed with compound 1monomer387-713
100ZN;MG;MKU;
Crystal structure of the catalytic domain of PDE4D2 with compound 12cmonomer386-712
100ZN;EDO;JN8;
Crystal structure of the catalytic domain of PDE4D2 with compound 10omonomer386-712
10013×EDO;ZN;PEG;JN7;
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 3,5-dimethyl-1-(3-nitro-phenyl)-1H-p…monomer388-713
100ZN;MG;7DE; 18×EDO;
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 3,5-dimethyl-1H-pyrazole-4-carboxyli…monomer388-713
100ZN;MG;DEE; 11×EDO;
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With Cilomilastmonomer388-713
100ZN;MG;CIO;EDO;
Crystal structure of PDE4D2 in complex with inhibitor (S_Zl-n-91)monomer388-713
100AKJ;ZN;MG;
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 3,5-dimethyl-1-phenyl-1H-pyrazole-4-…monomer388-713
100ZN;MG;3DE; 10×EDO;
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 1-(4-methoxy-phenyl)-3,5-dimethyl-1H…monomer388-713
100ZN;MG;4DE; 12×EDO;
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With Piclamilastmonomer388-713
100.0ZN;MG;PIL;B3P; 20×EDO;
Crystal structure of the PDE4D2 catalytic domain in complex with inhibitor (R)-Zl-n-91monomer388-713
100R91;ZN;MG;
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With Roflumilastmonomer388-713
100ZN;MG; 12×EDO;ROF;
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 1-(4-amino-phenyl)-3,5-dimethyl-1H-p…monomer388-713
100ZN;MG;5DE;EDO;
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With AMPmonomer389-713
100.0ZN;MG;AMP; 14×EDO;B3P;
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-1086monomer390-714
10011×EDO;D5Z;MG;ZN;EPE;
Crystal structure of PDE4D catalytic domain complexed with compound 18dmonomer388-712
100ZN;MG;1GF;
Crystal structure of the PDE4D catalytic domain in complex with ostholemonomer390-714
100ZN;A0O;
PDE4 crystal structure in complex with small molecule inhibitormonomer389-713
100.06PT;ZN;MG;
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With Zardaverinemonomer390-713
100.0ZN;MG;ZAR;
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With Roliprammonomer390-713
100.0ZN;MG;ROL;EDO;
Crystal structure of PDE4D catalytic domain complexed with 33amonomer390-713
100ZN;MG;8GO;
Crystal structure of PDE4D catalytic domain complexed with 17monomer390-713
100ZN;MG;8G7;
Crystal structure of PDE4D catalytic domain complexed with compound 4emonomer390-712
100M36;ZN;MG;
Crystal structure of PDE4D catalytic domain complexed with compound 17amonomer390-711
100ZN;MG;0X8;
Crystal structure of PDE4D catalytic domain complexed with compound 18amonomer393-712
100ZN;MG;1AS;
The structure of the RACK1 interaction sites located within the unique N-terminal region of the cAM…monomer250-280
29.03

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4wzi.1.Ahomo-2-mer0.76223-713
ZN;79.22

13 SWISS-MODEL models built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 24wzi.1.Ahomo-2-mer0.7687-577
ZN;79.22
Isoform 34wzi.1.Ahomo-2-mer0.7618-508
ZN;78.76
Isoform 44wzi.1.Ahomo-2-mer0.7845-488
ZN;80.68
Isoform 54wzi.1.Ahomo-2-mer0.801-411
ZN;82.51
Isoform 64wzi.1.Ahomo-2-mer0.76159-649
ZN;79.22
Isoform 61e9k.1.Amonomer0.6012-49
100.00
Isoform 71e9k.1.Amonomer0.6512-49
100.00
Isoform 84wzi.1.Ahomo-2-mer0.8016-422
ZN;80.43
Isoform 94wzi.1.Ahomo-2-mer0.76101-591
ZN;80.67
Isoform 94rxo.2.Ahomo-2-mer0.50305-393
22.37
Isoform 104wzi.1.Ahomo-2-mer0.7693-583
ZN;79.22
Isoform 114wzi.1.Ahomo-2-mer0.75162-652
ZN;79.22
Isoform 121e9k.1.Amonomer0.6412-49
100.00